There was a consistent trend toward lower fasting blood glucose levels (AAV-ACY1 [149.8 ± 5.71 mg/dL] versus AAV-GFP [162.4 ± 4.21 mg/dL]; P = 0.11; Figure 6F ), although this did not reach statistical significance — perhaps due to chronic increases in insulin levels and subsequent compensatory pathways.
← all excerpts
Proteomic profiling reveals biomarkers and pathways in type 2 diabetes risk.
2
—
—
The sentences
We identified dozens of markers with highly significant associations with future T2DM across 2 large longitudinal cohorts ( n = 2839) followed for up to 16 years.